Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This multicenter, prospective, open-label, outpatient study will assess the safety and
efficacy of HO/03/03 10µg applied topically once daily for up to 24 weeks in up to 100
subjects with Hard to Heal documented chronic wounds of various etiologies (pressure ulcers,
diabetic ulcers, post operational wounds surgical incisions ulcers of rheumatoid arthritis
and trauma wounds) of at least 4 weeks documentation.